Humana Faces Decline in Medicare Advantage Membership for 2025
Significant Decline in Medicare Advantage Membership at Humana
Humana, known for its Medicare Advantage plans, has revealed a notable decline in membership for 2025. This reduction has led to approximately a 12% drop in the insurer's shares during premarket trading, illustrating the financial impact of the news.
Details of the Membership Decline
The company announced that about 1.6 million members, amounting to 25% of its total member base, are enrolled in plans rated 4 stars and above for the upcoming year. This is a sharp decrease from 94% in 2024, highlighting a significant shift in member enrollment.
Understanding Star Rating Changes
The changes are reflected in the star ratings, which dropped from 4.5 to 3.5 for a major contract that constitutes roughly 45% of Humana's Medicare Advantage memberships. This decline in ratings not only affects member engagement but also plays a crucial role in quality assessments that can influence future enrollments.
Impact on Future Bonus Payments
As stated by the company, this decrease in star ratings is likely to affect its quality bonus payments in 2026. Therefore, the repercussions of this membership drop may have long-lasting financial effects.
Upcoming Star Rating Announcement
Star rating details for the year 2025 are anticipated to be formally released by the Centers for Medicare & Medicaid Services around mid-October. These ratings are crucial as they directly affect the operational dynamics of Medicare plans across the board.
Frequently Asked Questions
What caused the decline in Humana's Medicare Advantage membership?
The reduction in Humana's Medicare Advantage membership is attributed to a significant drop in the number of members enrolled in higher-rated plans for 2025, impacting overall company performance.
How will lower star ratings affect Humana financially?
Lower star ratings may lead to decreased quality bonus payments in 2026, potentially influencing Humana's financial stability in the future.
When will the official star ratings for 2025 be announced?
The official star ratings for 2025 are expected to be announced by the Centers for Medicare & Medicaid Services around October 10th.
What percentage of members are currently enrolled in 4-star plans?
Currently, only 25% of Humana's total members are enrolled in plans rated 4 stars and above for the 2025 year.
What proportion of Humana's membership is affected by the contract reduction?
The contract that saw a drop in star ratings accounts for about 45% of Humana's overall Medicare Advantage memberships.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Innovative Bioelectronic Implant Set to Transform Diabetes Treatment
- A2Z Cust2Mate Solutions Unveils Innovative Share Offering
- Empowering Churches: The State of the Church Initiative
- Benchmark Upholds Buy Rating for J.B. Hunt Amid Challenges
- Republic Services Unveils Circularity Index for Sustainable Business Practices
- Graeter's Ice Cream Unveils Exciting Holiday Flavors and More
- 5E Advanced Materials Welcomes Mark Zamek as VP for Products
- GetInsured Partners with BeWell to Transform Health Coverage
- Truist Boosts Price Target for Willis Towers Watson Amid Changes
- Mizuho's Optimistic Outlook for CVS Health's Future Prospects
Recent Articles
- Navigating Nasdaq 100: Challenges Amid Global Tensions
- Emergent BioSolutions Secures $100 Million Credit Facility
- PharmaCorp Expands Its Network with New Pharmacy Acquisition
- Promising Sale: Yorbeau's Rouyn Property Transaction with Lac Gold
- Verrica Pharmaceuticals Restructures for Enhanced Growth
- Rio2 Limited Secures Essential Permits for Fenix Gold Project
- Transforming Literature Access: Legible and CAMB.AI Partnership
- Titan Medical Alters Board Composition with Resignations
- Consolidated Lithium Metals Showcases Promising Drill Results
- Prairie Operating Co. Expands with Major Acquisition in DJ Basin
- Beyond Air's Innovative Partnership Expands Access to LungFit® PH
- Abcourt Mines Initiates Promising Drilling at Sleeping Giant
- Macerich to Announce Earnings: Key Details and Insights
- Tom Eldridge Takes Business Development Lead at HydroGraph
- Vimeo Welcomes Charlie Ungashick as New CMO to Propel Growth
- Cognition Therapeutics to Showcase Innovations in Neuroscience
- Blue Point Brewing's 20th Cask Ales Festival Set for November
- Kelli Kast Joins Bunker Hill Mining Corp Board as Chair
- Man Group PLC and Smith (DS) plc Open Position Disclosure
- CGI Secures Major Contract for Cloud Services with U.S. Government
- ROCKWOOL A/S Share Buy-Back Program Update and Insights
- LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement
- Man Group PLC's Strategic Stake in Ascential plc Disclosed
- Marex Group's Strategic Move with Aarna Capital Acquisition
- Daniel Ek's Strategic Non-Competition with Zuckerberg in Sports
- Are PEPE, WIF, and POPCAT Set to Eclipse Shiba Inu in 2024?
- Dr. Martin Gershon to Inspire at Upcoming Investor Capital Expo
- Elon Musk Critiques Tim Walz's Controversial Debate Remarks
- Civista Bancshares Prepares for Q3 2024 Financial Results Release
- Eli Lilly Poised for Trillion-Dollar Milestone Amid Challenges
- Aviation American Gin Unveils Exclusive Travel Retail Offering
- Veeva MedTech Partners with Top Medtech Companies for Innovation
- Essential Steps to Shield Your Baby from RSV This Winter
- Mizuho Optimizes Target for Eversource Energy Amid Changes
- Pando Electric Innovates EV Charging Solutions for Tomorrow
- JPMorgan Boosts Science Applications Stock to Overweight Rating
- National Libraries Rally for the Freedom to Read Initiative
- JD.com Gains Momentum with New Price Target and Buyback Plan
- Carrier Global Corporation Strengthens Focus with Major Sale
- Vimeo Welcomes Charlie Ungashick as Chief Marketing Officer
- Aurora Cannabis Partners with UBC to Explore Aroma Genetics
- Marex Group's Strategic Expansion with Aarna Capital Acquisition
- Energy Fuels Expands Horizons with Base Resources Acquisition
- Zepp Health Surpasses NYSE Challenges and Strengthens Future Growth
- Procore Technologies: Navigating New Strategies for Growth
- RedRover Mobilizes to Shelter Animals Affected by Hurricane
- Massive Demonstrations Erupt as Argentina Faces Education Crisis
- The Rising Cosmetic Esters Market: Trends and Insights 2024-2034
- Optimism Grows Around iPhone 16 Performance This Year
- Blue Moon Metals Inc. Engages in Asset Sale to Honey Badger